Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
21/08/2026 05:18
BUZZ-Australia's Island Pharmaceuticals rises as company boosts Galidesivir production ** Shares of Island Pharmaceuticals ILA.AX rise as much as 8.7% to A$0.5, their highest level since July 14
** The drug repurposing company commissions additional production campaign of GMP-grade Galidesivir with global contract research, development, and manufacturing
organisation, PI Health Sciences** Campaign to materially expand ILA's available supply of Galidesivir for active outbreak response and broader biodefence opportunities
** As of Tuesday, confirmed Ebola cases in the Democratic Republic of Congo had surpassed 5,000, the country's largest Ebola outbreak on record by case count
** About 643,000 shares change hands, 2.8 times the 30-day
** Stock up ~15% YTD, including the session's moves
(Reporting by Anjali Singh in Bengaluru)
Recent news on Island Pharmaceuticals
See all newsBrief: Island Pharmaceuticals Says Pivotal Marburg Data Secured For Galidesivir FDA Pathway
Brief: Island Pharmaceuticals Posts Prelim FY Loss Attributable Of A$9.8 Million
Australia's Island Pharmaceuticals rises as company boosts Galidesivir production
Brief: Island Pharmaceuticals Boosts Galidesivir Supply As Ebola Surges
Island Pharmaceuticals hits seven-month high on Galidesivir approval for Ebola epidemic